*001689424
*00520180226123700.0
*007ta
*008160921s2016    no a     m    00  0 eng
*00901424nam a2200289 c 4500
*019  $bl
*020  $a978-82-326-1860-6$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)999920163069802201
*035  $a(NO-LaBS)14982203(bibid)
*040  $aNO-OsNB$bnob$ekatreg
*0410 $aeng$bnob
*08204$a616.99433$223/nor$qNO-OsNB
*1001 $aBringeland, Erling A.$d1957-$0(NO-TrBIB)90627974$4aut$_95980900
*24510$aGastric Adenocarcinoma in central Norway :$bincidence, treatment and long term survival rates, with emphasis on outcomes after introducing perioperative chemotheraphy$cErling A. Bringeland
*260  $aTrondheim$bNorwegian University of Science and Technology, Faculty of Medicine, Department of Cancer Research and Molecular Medicine$c2016
*300  $a1 b. (flere pag.)$bill. (noen kol.)$c26 cm
*4901 $aDoctoral theses at NTNU$v2016:261
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Norges teknisk-naturvitenskapelige universitet, Trondheim, 2016
*546  $aSammendrag på norsk
*651 7$aMidt-Norge$2norbok$_188875700
*7102 $aNorges teknisk-naturvitenskapelige universitet$0(NO-TrBIB)90866400$4pbl$_10132100
*7102 $aNorges teknisk-naturvitenskapelige universitet$bInstitutt for kreftforskning og molekylær medisin$0(NO-TrBIB)10019256$4dgg$_204439500
*830 0$aDoktoravhandlinger ved NTNU (trykt utg.)$x1503-8181$v2016:261$w990402410684702201$_10123500
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999919856099702202$b2021-11-14T20:42:19Z$z999919856099702202
^